Far out question for the experts hereSo safe to say PMN is struggling with making progress getting FDA approval. Not a knock against them, they could have an game changing product.
But is this the only way forward? If it is and the only way to achieve that is to be bought by a larger company that can pay for the approval (judging from Biogen, approvals are purchased and probably gatekept) would it be possible to attempt to gain approval in other countries? If, I don't know, say Brazil begins accepting the use of PMN 310 for Alzheimer's patients that volunteer to try it, possibly as a last resort - could success there snowball further? Could it, if it's having success treating patients, put pressure on the FDA? There must be countries that would be willing to have their alzheimer's patients / families at least given the option to try cutting edge tech. Promis may need to guarantee the country's government the medication at a specific price for the next X years so if the medication is successful, they stand to win in some sense.
Food for thought. Am I crazy here?